Research ArticleClinical Studies

Side-effects of Pre-operative Epirubicin-Paclitaxel Therapy in Primary Breast Cancer Associated with Tumor Biology

MATHIAS WARM, RONALD KATES, ANKE THOMAS, THOMAS FISCHER and NADIA HARBECK
Anticancer Research July 2009, 29 (7) 2675-2680;

Article Information

vol. 29 no. 7 2675-2680
PMID 
19596945
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received December 23, 2008
  • Revision received March 19, 2009
  • Accepted April 6, 2009
  • Published online July 13, 2009.
Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MATHIAS WARM1,
  2. RONALD KATES2,
  3. ANKE THOMAS3,
  4. THOMAS FISCHER4 and
  5. NADIA HARBECK1
  1. 1Department of Senology, University of Cologne, Cologne
  2. 2REK Consulting, Otterfing
  3. 3Department of Obstetrics and Gynecology, University Berlin, Charité, Germany
  4. 4Institute of Radiology, University Berlin, Charité, Germany
  1. Correspondence to: Dr. med. Mathias Warm, Department of Senology, Kerpener Straße 62, 50924 Köln, Germany. Tel: +49 22147886545, Fax: +49 22147886546, e-mail: mathias.warm{at}ukkoeln.de
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Side-effects of Pre-operative Epirubicin-Paclitaxel Therapy in Primary Breast Cancer Associated with Tumor Biology
MATHIAS WARM, RONALD KATES, ANKE THOMAS, THOMAS FISCHER, NADIA HARBECK
Anticancer Research Jul 2009, 29 (7) 2675-2680;
Twitter logo Facebook logo Mendeley logo

Jump to section